YCBD News & Events

cbdMD announced the appointment of Wade Brown as Chief Marketing Officer. "Brown joined cbdMD in March 2025 and has been central to stabilizing the Company's brand portfolio and supporting its acquisition of Bluebird Botanicals. Most recently, cbdMD reported 19% year-over-year and 12% sequential revenue growth, supported by continued momentum in its core brands and the integration of Bluebird. Prior to joining cbdMD, Brown held senior marketing and growth leadership roles across a range of consumer brands, including NatureWise, Vanity Planet, Inc Authority, First Tactical, Noble Outfitters, and Kevin's Naturals. His experience spans dietary supplements, beauty, online services, and omnichannel CPG, with deep expertise in ecommerce, Amazon, performance marketing, and brand portfolio growth," the company stated.

cbdMD trading resumes

cbdMD announced that it has entered into securities purchase agreements with institutional investors whereby company issued the investors an aggregate of 1M shares of Series C convertible preferred stock in consideration of gross proceeds to the company of $2.25M. The company intends to use the net proceeds of approximately $2.1M for working capital general corporate purposes and support ongoing strategic initiatives. The Series C shares have a 10% annual dividend and are convertible at the option of the holder into the company's common stock at an initial conversion price of $2.25 per share, subject to certain anti-dilution protection provisions, with rights and preferences substantially the same as the company's issued and outstanding Series B convertible preferred stock.

cbdMD trading halted, news pending